CARISOPRODOL

Carisoprodol Adverse Events Reported to the FDA Over Time

How are Carisoprodol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Carisoprodol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Carisoprodol is flagged as the suspect drug causing the adverse event.

Most Common Carisoprodol Adverse Events Reported to the FDA

What are the most common Carisoprodol adverse events reported to the FDA?

Completed Suicide	836 (14.47%)
Respiratory Arrest	444 (7.69%)
Cardiac Arrest	441 (7.64%)
Cardio-respiratory Arrest	257 (4.45%)
Drug Abuse	167 (2.89%)
Drug Toxicity	167 (2.89%)
Intentional Drug Misuse	144 (2.49%)
Death	135 (2.34%)
Multiple Drug Overdose	134 (2.32%)
Poisoning	123 (2.13%)
Overdose	73 (1.26%)
	Show More
Multiple Drug Overdose Intentional	66 (1.14%)
Unresponsive To Stimuli	50 (.87%)
Coma	44 (.76%)
Drug Ineffective	39 (.68%)
Accidental Death	38 (.66%)
Loss Of Consciousness	36 (.62%)
Hypotension	35 (.61%)
Drug Abuser	33 (.57%)
Depression	32 (.55%)
Agitation	30 (.52%)
Aspartate Aminotransferase Increase...	29 (.5%)
Pulmonary Congestion	29 (.5%)
Somnolence	29 (.5%)
Incorrect Dose Administered	28 (.48%)
Intentional Overdose	28 (.48%)
Pulmonary Oedema	28 (.48%)
Road Traffic Accident	27 (.47%)
Suicide Attempt	27 (.47%)
Alanine Aminotransferase Increased	25 (.43%)
Insomnia	23 (.4%)
Confusional State	22 (.38%)
Depressed Level Of Consciousness	22 (.38%)
Drug Dependence	22 (.38%)
Lethargy	22 (.38%)
Tachycardia	22 (.38%)
Vomiting	22 (.38%)
Mental Status Changes	21 (.36%)
Blood Ph Decreased	20 (.35%)
Drug Screen Positive	19 (.33%)
Sinus Tachycardia	19 (.33%)
Constipation	18 (.31%)
Miosis	18 (.31%)
Accidental Overdose	17 (.29%)
Dehydration	17 (.29%)
Heart Rate Increased	17 (.29%)
Visual Impairment	17 (.29%)
Anxiety	16 (.28%)
Delirium	16 (.28%)
Hallucination, Visual	16 (.28%)
Pain	16 (.28%)
Tremor	16 (.28%)
Weight Decreased	16 (.28%)
Brain Oedema	15 (.26%)
Convulsion	15 (.26%)
Disorientation	14 (.24%)
Multi-organ Failure	14 (.24%)
Multiple Drug Overdose Accidental	14 (.24%)
Nausea	14 (.24%)
Substance Abuse	14 (.24%)
Suicidal Ideation	14 (.24%)
Memory Impairment	13 (.23%)
Neck Pain	13 (.23%)
Prothrombin Time Prolonged	13 (.23%)
Respiratory Depression	13 (.23%)
Aspiration	12 (.21%)
Cardiac Disorder	12 (.21%)
Dyspnoea	12 (.21%)
Fatigue	12 (.21%)
Hyperhidrosis	12 (.21%)
Pneumonia Aspiration	12 (.21%)
Poisoning Deliberate	12 (.21%)
Wrong Technique In Drug Usage Proce...	12 (.21%)
Back Pain	11 (.19%)
Blood Glucose Increased	11 (.19%)
Drug Withdrawal Syndrome	11 (.19%)
Haematocrit Decreased	11 (.19%)
Medication Error	11 (.19%)
Muscle Spasms	11 (.19%)
Pupillary Reflex Impaired	11 (.19%)
Accidental Exposure	10 (.17%)
Blood Pressure Decreased	10 (.17%)
Decreased Appetite	10 (.17%)
Drowning	10 (.17%)
Haemoglobin Decreased	10 (.17%)
Injury	10 (.17%)
Respiratory Rate Increased	10 (.17%)
Tachypnoea	10 (.17%)
Urinary Tract Infection	10 (.17%)
Activities Of Daily Living Impaired	9 (.16%)
Aggression	9 (.16%)
Amnesia	9 (.16%)
Drug Interaction	9 (.16%)
Dysarthria	9 (.16%)
Headache	9 (.16%)
International Normalised Ratio Incr...	9 (.16%)
Intervertebral Disc Protrusion	9 (.16%)
Rash	9 (.16%)
Respiratory Rate Decreased	9 (.16%)
Asthenia	8 (.14%)
Blood Creatinine Increased	8 (.14%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Carisoprodol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Carisoprodol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Carisoprodol

What are the most common Carisoprodol adverse events reported to the FDA?

Suicidal And Self-injurious Behavio...	885 (15.32%)
Cardiac Arrhythmias	763 (13.21%)
Respiratory	536 (9.28%)
Medication Errors	411 (7.12%)
Psychiatric	380 (6.58%)
Chemical Injury And Poisoning	315 (5.45%)
Neurological	277 (4.8%)
Fatal Outcomes	192 (3.32%)
Injuries	88 (1.52%)
Therapeutic And Nontherapeutic Effe...	82 (1.42%)
Metabolic, Nutritional And Blood Ga...	79 (1.37%)
	Show More
Lower Respiratory Tract Disorders	74 (1.28%)
Hepatobiliary	73 (1.26%)
Cardiac And Vascular Investigations	71 (1.23%)
Anxiety Disorders	59 (1.02%)
Lifestyle Issues	59 (1.02%)
Gastrointestinal Signs	57 (.99%)
Hematology Investigations	57 (.99%)
Ocular Neuromuscular	55 (.95%)
Deliria	52 (.9%)
Physical Examination Topics	44 (.76%)
Musculoskeletal And Connective Tiss...	40 (.69%)
Hepatic And Hepatobiliary	39 (.68%)
Decreased And Nonspecific Blood Pre...	38 (.66%)
Depressed Mood Disorders	33 (.57%)
Toxicology And Therapeutic Drug Mon...	33 (.57%)
Movement Disorders	30 (.52%)
Water, Electrolyte And Mineral	29 (.5%)
Epidermal And Dermal Conditions	26 (.45%)
Mental Impairment	26 (.45%)
Renal And Urinary Tract Investigati...	26 (.45%)
Sleep Disorders	25 (.43%)
Disturbances In Thinking	24 (.42%)
Infections - Pathogen Unspecified	24 (.42%)
Seizures	24 (.42%)
Vision	24 (.42%)
Electrolyte And Fluid Balance Condi...	21 (.36%)
Gastrointestinal Motility And Defec...	21 (.36%)
Cardiac Disorder Signs	20 (.35%)
Muscle	20 (.35%)
Urinary Tract Signs	19 (.33%)
Coronary Artery	18 (.31%)
Increased Intracranial Pressure And...	18 (.31%)
Personality Disorders	18 (.31%)
Enzyme	16 (.28%)
Myocardial	16 (.28%)
Musculoskeletal And Connective Tiss...	15 (.26%)
Product Quality Issues	15 (.26%)
Renal Disorders	15 (.26%)
Changes In Physical Activity	14 (.24%)
Joint	13 (.23%)
Skin Appendage Conditions	12 (.21%)
Tissue	12 (.21%)
Allergic Conditions	11 (.19%)
Appetite And General Nutritional	11 (.19%)
Mood Disorders	11 (.19%)
Bacterial Infectious	10 (.17%)
Body Temperature Conditions	10 (.17%)
Bone And Joint Injuries	10 (.17%)
Acid-base	9 (.16%)
Angiedema And Urticaria	9 (.16%)
Headaches	9 (.16%)
Pulmonary Vascular	9 (.16%)
Dementia And Amnestic Conditions	8 (.14%)
Neurological, Special Senses And Ps...	8 (.14%)
Procedural And Device Related Injur...	8 (.14%)
Protein And Chemistry Analyses	8 (.14%)
Psychiatric And Behavioural Symptom...	8 (.14%)
Exocrine Pancreas Conditions	7 (.12%)
Schizophrenia And Other Psychotic	6 (.1%)
Spinal Cord And Nerve Root	6 (.1%)
Viral Infectious	6 (.1%)
Bone Disorders	5 (.09%)
Encephalopathies	5 (.09%)
Skin Vascular Abnormalities	5 (.09%)
Structural Brain	5 (.09%)
Vascular Hypertensive	5 (.09%)
Central Nervous System Vascular	4 (.07%)
Dissociative	4 (.07%)
Gastrointestinal Conditions	4 (.07%)
Gastrointestinal Hemorrhages	4 (.07%)
Neuromuscular	4 (.07%)
Obstetric And Gynecological Therape...	4 (.07%)
Oral Soft Tissue Conditions	4 (.07%)
Peripheral Neuropathies	4 (.07%)
Sleep Disturbances	4 (.07%)
Arteriosclerosis, Stenosis, Vascula...	3 (.05%)
Bladder And Bladder Neck Disorders	3 (.05%)
Bronchial Disorders	3 (.05%)
Coagulopathies And Bleeding Diathes...	3 (.05%)
Eye	3 (.05%)
Gastrointestinal	3 (.05%)
Glucose Metabolism Disorders	3 (.05%)
Hepatic And Biliary Neoplasms Benig...	3 (.05%)
Inner Ear And Viiith Cranial Nerve	3 (.05%)
Legal Issues	3 (.05%)
Nervous System Neoplasms Benign	3 (.05%)
Nervous System, Skull And Spine The...	3 (.05%)
Peritoneal And Retroperitoneal Cond...	3 (.05%)
Therapeutic Procedures And Supporti...	3 (.05%)
Upper Respiratory Tract Disorders	3 (.05%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Carisoprodol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Carisoprodol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.